197 related articles for article (PubMed ID: 3555581)
1. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Karbwang J; Looareesuwan S; Phillips RE; Wattanagoon Y; Molyneux ME; Nagachinta B; Back DJ; Warrell DA
Br J Clin Pharmacol; 1987 Apr; 23(4):477-81. PubMed ID: 3555581
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
4. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
5. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
[TBL] [Abstract][Full Text] [Related]
6. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Niklewski G; Landscheidt H; Glasner H
Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
[No Abstract] [Full Text] [Related]
7. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; LindegÄrdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
10. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
11. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
[TBL] [Abstract][Full Text] [Related]
12. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
13. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
14. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
15. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
16. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
[TBL] [Abstract][Full Text] [Related]
17. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
18. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
19. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
20. Mefloquine-resistant falciparum malaria on the Thai-Burmese border.
Nosten F; ter Kuile F; Chongsuphajaisiddhi T; Luxemburger C; Webster HK; Edstein M; Phaipun L; Thew KL; White NJ
Lancet; 1991 May; 337(8750):1140-3. PubMed ID: 1674024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]